المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_1_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302935

الاتاحة: https://doi.org/10.6084/m9.figshare.14302935.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_2_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302938

الاتاحة: https://doi.org/10.6084/m9.figshare.14302938.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_5_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302950

الاتاحة: https://doi.org/10.6084/m9.figshare.14302950.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_4_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302947

الاتاحة: https://doi.org/10.6084/m9.figshare.14302947.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_6_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302953

الاتاحة: https://doi.org/10.6084/m9.figshare.14302953.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_3_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302941

الاتاحة: https://doi.org/10.6084/m9.figshare.14302941.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_8_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302959

الاتاحة: https://doi.org/10.6084/m9.figshare.14302959.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_9_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302962

الاتاحة: https://doi.org/10.6084/m9.figshare.14302962.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_7_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302956

الاتاحة: https://doi.org/10.6084/m9.figshare.14302956.v1